4basebio PLC (AIM:4BB)

London flag London · Delayed Price · Currency is GBP · Price in GBX
991.00
+21.00 (2.16%)
Jul 28, 2025, 8:35 AM GMT+1
2.16%
Market Cap150.13M
Revenue (ttm)933.00K
Net Income (ttm)-12.33M
Shares Out15.48M
EPS (ttm)-0.94
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19
Average Volume1,705
Open991.00
Previous Close970.00
Day's Range991.00 - 991.00
52-Week Range940.00 - 1,550.00
Beta1.00
RSI31.88
Earnings DateSep 19, 2025

About 4basebio

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5’ and 3’ ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccine... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 110
Stock Exchange London Stock Exchange AIM
Ticker Symbol 4BB
Full Company Profile

Financial Performance

In 2024, 4basebio's revenue was 933,000, an increase of 84.39% compared to the previous year's 506,000. Losses were -12.33 million, 60.9% more than in 2023.

Financial Statements

News

There is no news available yet.